203 related articles for article (PubMed ID: 11149424)
41. Transactivation via RAR/RXR-Sp1 interaction: characterization of binding between Sp1 and GC box motif.
Shimada J; Suzuki Y; Kim SJ; Wang PC; Matsumura M; Kojima S
Mol Endocrinol; 2001 Oct; 15(10):1677-92. PubMed ID: 11579201
[TBL] [Abstract][Full Text] [Related]
42. Retinoid-dependent in vitro transcription mediated by the RXR/RAR heterodimer.
Valcárcel R; Holz H; Jiménez CG; Barettino D; Stunnenberg HG
Genes Dev; 1994 Dec; 8(24):3068-79. PubMed ID: 8001825
[TBL] [Abstract][Full Text] [Related]
43. Differential regulation of human ectocervical epithelial cell line proliferation and differentiation by retinoid X receptor- and retinoic acid receptor-specific retinoids.
Agarwal C; Chandraratna RA; Teng M; Nagpal S; Rorke EA; Eckert RL
Cell Growth Differ; 1996 Apr; 7(4):521-30. PubMed ID: 9052993
[TBL] [Abstract][Full Text] [Related]
44. Retinoic acid receptor alpha expression correlates with retinoid-induced growth inhibition of human breast cancer cells regardless of estrogen receptor status.
Fitzgerald P; Teng M; Chandraratna RA; Heyman RA; Allegretto EA
Cancer Res; 1997 Jul; 57(13):2642-50. PubMed ID: 9205071
[TBL] [Abstract][Full Text] [Related]
45. Potentiation of VD-induced monocytic leukemia cell differentiation by retinoids involves both RAR and RXR signaling pathways.
Defacque H; Sévilla C; Piquemal D; Rochette-Egly C; Marti J; Commes T
Leukemia; 1997 Feb; 11(2):221-7. PubMed ID: 9009084
[TBL] [Abstract][Full Text] [Related]
46. Physiological and retinoid-induced proliferations of epidermis basal keratinocytes are differently controlled.
Chapellier B; Mark M; Messaddeq N; Calléja C; Warot X; Brocard J; Gérard C; Li M; Metzger D; Ghyselinck NB; Chambon P
EMBO J; 2002 Jul; 21(13):3402-13. PubMed ID: 12093741
[TBL] [Abstract][Full Text] [Related]
47. Ligand-dependent activation of transcription in vitro by retinoic acid receptor alpha/retinoid X receptor alpha heterodimers that mimics transactivation by retinoids in vivo.
Dilworth FJ; Fromental-Ramain C; Remboutsika E; Benecke A; Chambon P
Proc Natl Acad Sci U S A; 1999 Mar; 96(5):1995-2000. PubMed ID: 10051583
[TBL] [Abstract][Full Text] [Related]
48. Blocking activator protein-1 activity, but not activating retinoic acid response element, is required for the antitumor promotion effect of retinoic acid.
Huang C; Ma WY; Dawson MI; Rincon M; Flavell RA; Dong Z
Proc Natl Acad Sci U S A; 1997 May; 94(11):5826-30. PubMed ID: 9159159
[TBL] [Abstract][Full Text] [Related]
49. Transcriptional induction of mitogen-activated protein kinase phosphatase 1 by retinoids. Selective roles of nuclear receptors and contribution to the antiapoptotic effect.
Xu Q; Konta T; Furusu A; Nakayama K; Lucio-Cazana J; Fine LG; Kitamura M
J Biol Chem; 2002 Nov; 277(44):41693-700. PubMed ID: 12186877
[TBL] [Abstract][Full Text] [Related]
50. Retinoid receptors cause distortion of the retinoic acid response element in the phosphoenolpyruvate carboxykinase gene promoter.
Scott DK; Hall RK; Granner DK
Biochem J; 1995 Sep; 310 ( Pt 2)(Pt 2):483-90. PubMed ID: 7654186
[TBL] [Abstract][Full Text] [Related]
51. Both retinoic-acid-receptor- and retinoid-X-receptor-dependent signalling pathways mediate the induction of the brown-adipose-tissue-uncoupling-protein-1 gene by retinoids.
Alvarez R; Checa M; Brun S; Viñas O; Mampel T; Iglesias R; Giralt M; Villarroya F
Biochem J; 2000 Jan; 345 Pt 1(Pt 1):91-7. PubMed ID: 10600643
[TBL] [Abstract][Full Text] [Related]
52. Mouse skin tumor progression results in differential expression of retinoic acid and retinoid X receptors.
Darwiche N; Celli G; Tennenbaum T; Glick AB; Yuspa SH; De Luca LM
Cancer Res; 1995 Jul; 55(13):2774-82. PubMed ID: 7540949
[TBL] [Abstract][Full Text] [Related]
53. Transcription suppression of thromboxane receptor gene expression by retinoids in vascular smooth muscle cells.
Uruno A; Sugawara A; Kudo M; Sato M; Sato K; Ito S; Takeuchi K
Hypertens Res; 2003 Oct; 26(10):815-21. PubMed ID: 14621185
[TBL] [Abstract][Full Text] [Related]
54. Expression of retinoid X receptors and COUP-TFI in a human salivary gland adenocarcinoma cell line.
Kyakumoto S; Nemoto T; Sato N; Ota M
Biochem Cell Biol; 1997; 75(6):749-58. PubMed ID: 9599664
[TBL] [Abstract][Full Text] [Related]
55. Synthetic retinoids dissociate coactivator binding from corepressor release.
Zechel C
J Recept Signal Transduct Res; 2002; 22(1-4):31-61. PubMed ID: 12503607
[TBL] [Abstract][Full Text] [Related]
56. Evidence for the involvement of retinoic acid receptor RAR alpha-dependent signaling pathway in the induction of tissue transglutaminase and apoptosis by retinoids.
Zhang LX; Mills KJ; Dawson MI; Collins SJ; Jetten AM
J Biol Chem; 1995 Mar; 270(11):6022-9. PubMed ID: 7890733
[TBL] [Abstract][Full Text] [Related]
57. Tumor promoter-induced ornithine decarboxylase gene expression occurs independently of AP-1 activation.
Jansen AP; Colburn NH; Verma AK
Oncogene; 1999 Oct; 18(42):5806-13. PubMed ID: 10523861
[TBL] [Abstract][Full Text] [Related]
58. Inhibition of rabbit collagenase (matrix metalloproteinase-1; MMP-1) transcription by retinoid receptors: evidence for binding of RARs/RXRs to the -77 AP-1 site through interactions with c-Jun.
Schroen DJ; Brinckerhoff CE
J Cell Physiol; 1996 Nov; 169(2):320-32. PubMed ID: 8908199
[TBL] [Abstract][Full Text] [Related]
59. Retinoic acid upregulates cone arrestin expression in retinoblastoma cells through a Cis element in the distal promoter region.
Li A; Zhu X; Craft CM
Invest Ophthalmol Vis Sci; 2002 May; 43(5):1375-83. PubMed ID: 11980849
[TBL] [Abstract][Full Text] [Related]
60. Transcriptional activation of a model reporter system by retinoids and retinoic acid receptor isoforms.
Huggenvik JI; Sharma RP
Pharmacol Toxicol; 1995 Jan; 76(1):17-22. PubMed ID: 7753751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
